Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Kevin F Mclaughlin. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Kevin F Mclaughlin har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:VCEL / Vericel Corporation | Director | 18 300 |
| US:IVVD / Invivyd, Inc. | Director | 50 000 |
| US:DBTX / Decibel Therapeutics Inc | Director | 0 |
| US:XLRN / Acceleron Pharma Inc | SVP, CFO and Treasurer | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Kevin F Mclaughlin. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IVVD / Invivyd, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IVVD / Invivyd, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | IVVD | MCLAUGHLIN KEVIN F | 50 000 | 2,5000 | 50 000 | 2,5000 | 125 000 | 33 | 2.8800 | 19 000 | 15,20 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IVVD / Invivyd, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp VCEL / Vericel Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IVVD / Invivyd, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IVVD / Invivyd, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Kevin F Mclaughlin som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −3 500 | 18 300 | −16,06 | 32,82 | −114 870 | 600 606 |
| 2026-05-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 500 | 21 800 | 19,13 | 13,05 | 45 675 | 284 490 | |
| 2026-05-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −3 500 | 18 300 | −16,06 | 32,83 | −114 905 | 600 789 |
| 2026-05-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 500 | 21 800 | 19,13 | 2,63 | 9 205 | 57 334 | |
| 2026-05-01 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 18 300 | 21,19 | ||||
| 2026-02-13 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 15 100 | −31,67 | 34,66 | −242 620 | 523 366 |
| 2026-02-13 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,63 | 18 410 | 58 123 | |
| 2025-11-20 |
|
4 | IVVD |
Invivyd, Inc.
Common Stock |
P - Purchase | 50 000 | 50 000 | 2,50 | 125 000 | 125 000 | ||
| 2025-11-12 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 15 100 | −31,67 | 38,59 | −270 130 | 582 709 |
| 2025-11-12 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,63 | 18 410 | 58 123 | |
| 2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 15 100 | −31,67 | 35,92 | −251 440 | 542 392 |
| 2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
| 2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 15 100 | −31,67 | 39,98 | −279 860 | 603 698 |
| 2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
| 2025-05-02 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 15 100 | 26,89 | ||||
| 2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −1 000 | 11 900 | −7,75 | 55,43 | −55 430 | 659 617 |
| 2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 000 | 12 900 | 8,40 | 2,76 | 2 760 | 35 604 | |
| 2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −6 000 | 11 900 | −33,52 | 55,47 | −332 820 | 660 093 |
| 2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 6 000 | 17 900 | 50,42 | 3,74 | 22 440 | 66 946 | |
| 2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −7 000 | 11 900 | −37,04 | 55,54 | −388 780 | 660 926 |
| 2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 18 900 | 58,82 | 3,74 | 26 180 | 70 686 | |
| 2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −2 000 | 11 900 | −14,39 | 45,99 | −91 980 | 547 281 |
| 2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 000 | 13 900 | 16,81 | 3,74 | 7 480 | 51 986 | |
| 2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | −5 000 | 11 900 | −29,59 | 45,92 | −229 600 | 546 448 |
| 2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 5 000 | 16 900 | 42,02 | 3,74 | 18 700 | 63 206 | |
| 2024-05-03 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 11 900 | 36,78 | ||||
| 2023-09-25 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | −5 000 | 0 | −100,00 | ||||
| 2023-06-14 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
A - Award | 5 000 | 5 000 | |||||
| 2023-04-28 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 8 700 | 42,62 | ||||
| 2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
| 2022-04-29 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
| 2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | −2 600 | 0 | −100,00 | ||||
| 2022-04-29 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 6 100 | 74,29 | ||||
| 2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −18 806 | 0 | −100,00 | ||||
| 2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −24 334 | 0 | −100,00 | ||||
| 2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −20 500 | 0 | −100,00 | ||||
| 2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −11 262 | 0 | −100,00 | ||||
| 2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | −2 663 | 0 | −100,00 | ||||
| 2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
U - Other | −10 681 | 0 | −100,00 | ||||
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −170 | 20 500 | −0,82 | |||
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 200 | 11 262 | −31,59 | |||
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 370 | 10 681 | −33,46 | 160,38 | −861 241 | 1 713 019 |
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 170 | 16 051 | 1,07 | 41,64 | 7 079 | 668 364 |
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 200 | 15 881 | 48,68 | 40,61 | 211 172 | 644 927 |
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 330 | 20 670 | −26,18 | |||
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −9 800 | 16 462 | −37,32 | |||
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 2 663 | −48,42 | |||
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −983 | 10 681 | −8,43 | 161,26 | −158 519 | 1 722 418 |
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −18 647 | 11 664 | −61,52 | 160,26 | −2 988 368 | 1 869 273 |
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 330 | 30 311 | 31,90 | 41,64 | 305 221 | 1 262 150 |
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 9 800 | 22 981 | 74,35 | 40,61 | 397 978 | 933 258 |
| 2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 13 181 | 23,41 | 30,17 | 75 425 | 397 671 |
| 2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
| 2021-04-30 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
| 2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | −1 750 | 0 | −100,00 | ||||
| 2021-04-30 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 3 500 | 100,00 | ||||
| 2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 18 806 | 18 806 | |||||
| 2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 868 | 10 681 | 83,74 | ||||
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 | 5 813 | −0,07 | 123,50 | −494 | 717 906 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −296 | 5 817 | −4,84 | 122,85 | −36 364 | 714 618 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −499 | 6 113 | −7,55 | 121,89 | −60 823 | 745 114 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 6 612 | −9,57 | 120,43 | −84 301 | 796 283 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 7 312 | −3,94 | 124,45 | −37 335 | 909 978 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −667 | 7 612 | −8,06 | 124,47 | −83 021 | 947 466 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 8 279 | −6,76 | 123,49 | −74 094 | 1 022 374 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 8 879 | −2,20 | 125,49 | −25 098 | 1 114 226 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −713 | 9 079 | −7,28 | 124,28 | −88 612 | 1 128 338 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 9 792 | −7,55 | 123,54 | −98 832 | 1 209 704 |
| 2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
F - Taxes | −624 | 10 592 | −5,56 | 124,31 | −77 569 | 1 316 692 | |
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 590 | 26 262 | −8,98 | |||
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −24 986 | 5 163 | −82,88 | |||
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 700 | 0 | −100,00 | |||
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 252 | 0 | −100,00 | |||
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −42 528 | 11 216 | −79,13 | 130,14 | −5 534 594 | 1 459 650 |
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 590 | 53 744 | 5,06 | 40,61 | 105 180 | 2 182 544 |
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 24 986 | 51 154 | 95,48 | 30,17 | 753 828 | 1 543 316 |
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 700 | 26 168 | 41,69 | 27,97 | 215 369 | 731 919 |
| 2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 252 | 18 468 | 64,66 | 41,20 | 298 782 | 760 882 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 100 | 7 252 | −29,95 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 100 | 11 216 | −21,65 | 125,00 | −387 500 | 1 402 000 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 100 | 14 316 | 27,64 | 41,20 | 127 720 | 589 819 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −100 | 28 852 | −0,35 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −100 | 28 852 | −0,35 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −100 | 30 149 | −0,33 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −200 | 7 700 | −2,53 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 11 216 | −4,27 | 125,12 | −62 560 | 1 403 346 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 716 | 0,86 | 40,61 | 4 061 | 475 787 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 616 | 0,87 | 30,17 | 3 017 | 350 455 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 200 | 11 516 | 1,77 | 27,97 | 5 594 | 322 103 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 316 | 0,89 | 41,20 | 4 120 | 466 219 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 873 | 28 952 | −6,08 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 051 | 30 249 | −3,36 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −400 | 7 900 | −4,82 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −548 | 10 452 | −4,98 | |||
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 872 | 11 216 | −25,66 | 125,03 | −484 116 | 1 402 336 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 873 | 15 088 | 14,17 | 40,61 | 76 063 | 612 724 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 051 | 13 215 | 8,64 | 30,17 | 31 709 | 398 697 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 400 | 12 164 | 3,40 | 27,97 | 11 188 | 340 227 |
| 2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 548 | 11 764 | 4,89 | 41,20 | 22 578 | 484 677 |
| 2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
| 2020-05-01 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
| 2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | −1 750 | 0 | −100,00 | 14,56 | −25 480 | ||
| 2020-05-01 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 1 750 | |||||
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −17 226 | 11 000 | −61,03 | |||
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −17 226 | 11 216 | −60,57 | 88,19 | −1 519 161 | 989 139 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 17 226 | 28 442 | 153,58 | 41,20 | 709 711 | 1 171 810 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 31 300 | −24,21 | |||
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 31 300 | −24,21 | |||
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −12 774 | 28 226 | −31,16 | |||
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 0 | −100,00 | |||
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 703 | 11 216 | −24,82 | 87,50 | −324 012 | 981 400 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 921 | 14 919 | −28,41 | 86,79 | −513 884 | 1 294 820 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −15 410 | 20 840 | −42,51 | 85,80 | −1 322 178 | 1 788 072 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 803 | 36 250 | −9,49 | 84,89 | −322 837 | 3 077 262 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 037 | 40 053 | −11,17 | 83,68 | −421 496 | 3 351 635 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 900 | 45 090 | −6,04 | 82,83 | −240 207 | 3 734 805 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 47 990 | 26,32 | 30,17 | 301 700 | 1 447 858 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 37 990 | 35,73 | 27,97 | 279 700 | 1 062 580 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 774 | 27 990 | 83,95 | 41,20 | 526 289 | 1 153 188 |
| 2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 15 216 | 35,66 | 24,11 | 96 440 | 366 858 |
| 2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 24 334 | 24 334 | |||||
| 2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 369 | 11 216 | 131,40 | ||||
| 2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 566 | 4 847 | −24,42 | 52,52 | −82 246 | 254 564 |
| 2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 300 | 6 413 | −26,40 | 52,49 | −120 727 | 336 618 |
| 2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 713 | 8 713 | −16,43 | 52,51 | −89 950 | 457 520 |
| 2019-12-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −11 853 | 10 426 | −53,20 | 50,28 | −595 969 | 524 219 |
| 2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −173 | 22 279 | −0,77 | 45,75 | −7 915 | 1 019 264 |
| 2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 827 | 22 452 | −25,85 | 45,29 | −354 485 | 1 016 851 |
| 2019-05-03 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
| 2019-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 30 279 | −0,33 | 45,46 | −4 546 | 1 376 483 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −11 900 | 30 379 | −28,15 | 44,61 | −530 859 | 1 355 207 |
| 2019-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −648 | 42 279 | −1,51 | 48,02 | −31 117 | 2 030 238 |
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 000 | 28 000 | |||||
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 700 | 42 927 | 12,29 | ||||
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −97 | 38 227 | −0,25 | 44,06 | −4 274 | 1 684 282 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 717 | 38 324 | −4,29 | 43,33 | −74 398 | 1 660 579 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 186 | 40 041 | −5,18 | 42,56 | −93 036 | 1 704 145 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 42 227 | −0,71 | 43,20 | −12 960 | 1 824 206 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 412 | 42 527 | −3,21 | 42,37 | −59 826 | 1 801 869 |
| 2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −12 500 | 18 300 | −40,58 | |||
| 2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −12 500 | 43 939 | −22,15 | 54,00 | −675 000 | 2 372 706 |
| 2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 500 | 56 439 | 28,45 | 27,97 | 349 625 | 1 578 599 |
| 2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −25 000 | 4 000 | −86,21 | |||
| 2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −12 500 | 43 939 | −22,15 | 49,00 | −612 500 | 2 153 011 |
| 2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −12 500 | 56 439 | −18,13 | 47,00 | −587 500 | 2 652 633 |
| 2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 25 000 | 68 939 | 56,90 | 24,11 | 602 750 | 1 662 119 |
| 2018-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 43 939 | −1,79 | 39,00 | −31 200 | 1 713 621 |
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 200 | 44 739 | −6,68 | 38,31 | −122 592 | 1 713 951 |
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 825 | 30 825 | |||||
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 138 | 47 939 | 12,00 | ||||
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 42 801 | −0,47 | 43,84 | −8 768 | 1 876 396 |
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −14 800 | 43 001 | −25,61 | 43,00 | −636 400 | 1 849 043 |
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 250 | 0 | −100,00 | ||||
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 251 | 0 | −100,00 | ||||
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 250 | 57 801 | 12,12 | 5,28 | 33 000 | 305 189 | |
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 251 | 51 551 | 13,80 | 3,88 | 24 254 | 200 018 | |
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 000 | 45 300 | −8,11 | 42,42 | −169 680 | 1 921 626 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −210 | 49 300 | −0,42 | 39,85 | −8 368 | 1 964 605 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 49 510 | −2,56 | 39,17 | −50 921 | 1 939 307 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −14 490 | 50 810 | −22,19 | 38,32 | −555 257 | 1 947 039 |
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −18 750 | 0 | −100,00 | |||
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 150 | 6 250 | −33,51 | |||
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −34 400 | 65 300 | −34,50 | 32,00 | −1 100 800 | 2 089 600 |
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 18 750 | 99 700 | 23,16 | 7,12 | 133 500 | 709 864 |
| 2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 150 | 80 950 | 4,05 | 5,28 | 16 632 | 427 416 |
| 2017-05-05 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 300 | 41 300 | |||||
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 900 | 77 800 | 9,73 | ||||
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 70 900 | −1,80 | 27,63 | −35 919 | 1 958 967 |
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 72 200 | −0,55 | 26,87 | −10 748 | 1 940 014 |
| 2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −10 000 | 6 251 | −61,53 | ||||
| 2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 72 600 | 15,97 | 3,88 | 38 800 | 281 688 | |
| 2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 16 251 | −23,53 | ||||
| 2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 62 600 | 8,68 | 3,88 | 19 400 | 242 888 | |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −15 300 | 9 400 | −61,94 | |||
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −25 300 | 57 600 | −30,52 | 34,66 | −876 898 | 1 996 416 |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 15 300 | 82 900 | 22,63 | 5,28 | 80 784 | 437 712 |
| 2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −300 | 24 700 | −1,20 | |||
| 2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −25 300 | 67 600 | −27,23 | 34,00 | −860 200 | 2 298 400 |
| 2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 300 | 92 900 | 0,32 | 5,28 | 1 584 | 490 512 |
| 2016-05-06 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 800 | 30 800 | |||||
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 100 | 92 600 | 5,83 | ||||
| 2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −7 500 | 21 251 | −26,09 | ||||
| 2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 500 | 87 500 | 9,38 | 3,88 | 29 100 | 339 500 | |
| 2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 28 751 | −19,58 | |||
| 2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 460 | 80 000 | −4,15 | 24,64 | −85 254 | 1 971 200 |
| 2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 540 | 83 460 | −4,07 | 24,12 | −85 385 | 2 013 055 |
| 2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 87 000 | 8,75 | 3,88 | 27 160 | 337 560 |
| 2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 40 000 | 80 000 | 100,00 | ||||
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 35 751 | −4,03 | |||
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 37 251 | −11,83 | |||
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −176 | 40 000 | −0,44 | 31,16 | −5 484 | 1 246 400 |
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −724 | 40 176 | −1,77 | 30,45 | −22 046 | 1 223 359 |
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 40 900 | −1,45 | 29,39 | −17 634 | 1 202 051 |
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 293 | 40 000 | −3,13 | 31,07 | −40 174 | 1 242 800 |
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 500 | 41 293 | −5,71 | 30,22 | −75 550 | 1 247 874 |
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 207 | 43 793 | −2,68 | 29,11 | −35 136 | 1 274 814 |
| 2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
| 2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 42 251 | −3,43 | |||
| 2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 43 751 | −10,26 | |||
| 2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 40 000 | −3,61 | 28,54 | −42 810 | 1 141 600 |
| 2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
| 2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 40 000 | −0,25 | 29,23 | −2 923 | 1 169 200 |
| 2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 900 | 40 100 | −10,89 | 28,51 | −139 699 | 1 143 251 |
| 2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
| 2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 48 751 | −9,30 | ||||
| 2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 | |
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 53 751 | −3,59 | |||
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 55 751 | −8,23 | |||
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −95 | 35 000 | −0,27 | 30,39 | −2 887 | 1 063 650 |
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 905 | 35 095 | −5,15 | 29,68 | −56 540 | 1 041 620 |
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 37 000 | 5,71 | 3,88 | 7 760 | 143 560 |
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −377 | 35 000 | −1,07 | 30,27 | −11 412 | 1 059 450 |
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 623 | 35 377 | −11,56 | 29,65 | −137 072 | 1 048 928 |
| 2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 |
| 2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 60 751 | −7,60 | ||||
| 2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 | |
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 65 751 | −2,23 | |||
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 67 251 | −6,92 | |||
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 30 000 | −0,66 | 32,96 | −6 592 | 988 800 |
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 30 200 | −4,13 | 32,37 | −42 081 | 977 574 |
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 31 500 | 5,00 | 3,88 | 5 820 | 122 220 |
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 30 000 | −0,33 | 32,97 | −3 297 | 989 100 |
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 900 | 30 100 | −14,00 | 32,49 | −159 201 | 977 949 |
| 2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 |
| 2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 72 251 | −6,47 | ||||
| 2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 500 | 77 251 | −7,76 | |||
| 2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 | |
| 2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 25 000 | −5,66 | 31,78 | −47 670 | 794 500 |
| 2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 26 500 | −0,38 | 32,40 | −3 240 | 858 600 |
| 2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 900 | 26 600 | −15,56 | 31,79 | −155 771 | 845 614 |
| 2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 500 | 31 500 | 26,00 | 3,88 | 25 220 | 122 220 |
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 83 751 | −5,63 | |||
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 88 751 | −2,20 | |||
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 25 000 | −1,96 | 35,50 | −17 750 | 887 500 |
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 500 | 25 500 | −15,00 | 34,80 | −156 600 | 887 400 |
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −250 | 25 000 | −0,99 | 35,52 | −8 880 | 888 000 |
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 750 | 25 250 | −6,48 | 34,82 | −60 935 | 879 205 |
| 2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
| 2015-03-24 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 90 751 | −1,63 | |||
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 92 251 | −5,14 | |||
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 25 000 | −0,79 | 40,94 | −8 188 | 1 023 500 |
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 25 200 | −4,91 | 40,14 | −52 182 | 1 011 528 |
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −619 | 25 000 | −2,42 | 40,93 | −25 336 | 1 023 250 |
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 381 | 25 619 | −14,60 | 40,16 | −175 941 | 1 028 859 |
| 2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
| 2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 97 251 | −1,52 | |||
| 2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 98 751 | −4,82 | |||
| 2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 25 000 | −5,66 | 36,65 | −54 975 | 916 250 |
| 2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
| 2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 25 000 | −1,57 | 37,11 | −14 844 | 927 750 |
| 2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 600 | 25 400 | −15,33 | 36,60 | −168 360 | 929 640 |
| 2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
| 2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 103 751 | −1,89 | |||
| 2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −845 | 25 000 | −3,27 | 41,04 | −34 679 | 1 026 000 |
| 2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 155 | 25 845 | −4,28 | 40,38 | −46 639 | 1 043 621 |
| 2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 105 751 | −4,51 | |||
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 300 | 25 000 | −14,68 | 39,59 | −170 237 | 989 750 |
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 29 300 | −2,33 | 38,67 | −27 069 | 1 133 031 |
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
| 2015-01-07 | 3 | VCEL |
Vericel Corp
No securities are beneficially owned |
0 | ||||||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −15 000 | 110 751 | −11,93 | ||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 15 000 | 25 000 | 150,00 | 3,88 | 58 200 | 97 000 | |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 125 751 | −7,37 | |||
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 10 000 | −0,99 | 47,64 | −4 764 | 476 400 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 10 100 | −1,94 | 46,76 | −9 352 | 472 276 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 10 300 | −2,83 | 45,79 | −13 737 | 471 637 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 10 600 | −13,11 | 44,84 | −71 744 | 475 304 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 12 200 | −8,27 | 44,21 | −48 631 | 539 362 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 13 300 | −8,90 | 42,86 | −55 718 | 570 038 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 14 600 | −1,35 | 41,18 | −8 236 | 601 228 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 14 800 | −1,33 | 39,52 | −7 904 | 584 896 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −196 | 15 000 | −1,29 | 47,23 | −9 257 | 708 450 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 15 196 | −1,94 | 46,39 | −13 917 | 704 942 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 15 496 | −6,06 | 45,17 | −45 170 | 699 954 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 759 | 16 496 | −9,64 | 44,34 | −77 994 | 731 433 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 344 | 18 255 | −6,86 | 42,96 | −57 738 | 784 235 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 19 599 | −0,51 | 41,14 | −4 114 | 806 303 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −201 | 19 699 | −1,01 | 40,34 | −8 108 | 794 658 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 19 900 | −0,50 | 38,52 | −3 852 | 766 548 |
| 2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 135 751 | −6,86 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 138 | 10 000 | −23,88 | 33,58 | −105 374 | 335 800 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 862 | 13 138 | −12,41 | 32,39 | −60 310 | 425 540 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 050 | 15 000 | −16,90 | 33,60 | −102 480 | 504 000 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 950 | 18 050 | −9,75 | 32,44 | −63 258 | 585 542 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
| 2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −10 000 | 145 751 | −6,42 | ||||
| 2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | ||
| 2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 155 751 | −6,03 | |||
| 2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −10 000 | 0 | −100,00 | 29,25 | −292 500 | |
| 2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | |
| 2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 700 | 165 751 | −3,89 | |||
| 2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −370 | 0 | −100,00 | 24,75 | −9 158 | |
| 2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 330 | 370 | −94,48 | 24,24 | −153 439 | 8 969 |
| 2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 700 | 6 700 | 3,88 | 25 996 | 25 996 | |
| 2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 300 | 172 451 | −1,88 | |||
| 2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 300 | 0 | −100,00 | 24,90 | −82 170 | |
| 2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 300 | 3 300 | 3,88 | 12 804 | 12 804 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 175 751 | −3,83 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 000 | 182 751 | −1,62 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 000 | 0 | −100,00 | 29,79 | −208 530 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 000 | 0 | −100,00 | 29,76 | −89 280 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 185 751 | −3,63 | |||
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 000 | 192 751 | −1,53 | |||
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 800 | 0 | −100,00 | 32,59 | −58 662 | |
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 200 | 1 800 | −74,29 | 31,42 | −163 384 | 56 556 |
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 0 | −100,00 | 32,56 | −26 048 | |
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 200 | 800 | −73,33 | 31,40 | −69 080 | 25 120 |
| 2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −7 000 | 195 751 | −3,45 | |||
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −3 000 | 202 751 | −1,46 | |||
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 197 | 0 | −100,00 | 31,98 | −134 220 | |
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 803 | 4 197 | −40,04 | 31,16 | −87 341 | 130 779 |
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 686 | 0 | −100,00 | 32,00 | −53 952 | |
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 314 | 1 686 | −43,80 | 31,17 | −40 957 | 52 553 |
| 2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 205 751 | −3,29 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 000 | 212 751 | −1,39 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −286 | 0 | −100,00 | 32,17 | −9 201 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 714 | 286 | −95,91 | 31,49 | −211 424 | 9 006 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 32,27 | −3 227 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 900 | 100 | −96,67 | 31,48 | −91 292 | 3 148 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
| 2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 |
